Prevalence of IDA in pregnancy - Idpas.org

2. Minimize Side Effects
• “There is little evidence that side effects are the
major cause of non-compliance” (Galloway,
1994).
• Blot, Simmons, IOM 2000
• with 65 mg x 3, 25% symptoms vs 13% placebo
• with 130 x 3
40% symptoms
• “unlikely that 60 mg x 2 would affect compliance”
IOM 1993